{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:16:30Z","timestamp":1783401390622,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["X-2309-2"],"award-info":[{"award-number":["X-2309-2"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370733"],"award-info":[{"award-number":["82370733"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LHDMZ23H310001"],"award-info":[{"award-number":["LHDMZ23H310001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Jinling Hospital","award":["22JCYYYB2"],"award-info":[{"award-number":["22JCYYYB2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08080-4","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:55:16Z","timestamp":1781841316000},"page":"4241-4253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus"],"prefix":"10.1007","volume":"45","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-049X","authenticated-orcid":false,"given":"Heng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"5\u20136","key":"8080_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.312561.118","volume":"32","author":"B Shan","year":"2018","unstructured":"Shan B, Pan H, Najafov A, Yuan J (2018) Necroptosis in development and diseases. Genes Dev 32(5\u20136):327\u2013340","journal-title":"Genes Dev"},{"issue":"1","key":"8080_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12967-019-1809-3","volume":"17","author":"J Jhun","year":"2019","unstructured":"Jhun J, Lee SH, Kim SY, Ryu J, Kwon JY, Na HS, Jung K, Moon SJ, Cho ML, Min JK (2019) RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis. J Transl Med 17(1):84","journal-title":"J Transl Med"},{"key":"8080_CR3","doi-asserted-by":"crossref","unstructured":"Nakano H (2024) Necroptosis and its involvement in various diseases, pp 129\u2013143","DOI":"10.1007\/978-981-99-9781-7_9"},{"issue":"8","key":"8080_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-020-0071-y","volume":"19","author":"L Mifflin","year":"2020","unstructured":"Mifflin L, Ofengeim D, Yuan J (2020) Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat Rev Drug Discov 19(8):553\u2013571","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"8080_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdermsci.2020.06.001","volume":"99","author":"L Jin","year":"2020","unstructured":"Jin L, Liu P, Yin M, Zhang M, Kuang Y, Zhu W (2020) RIPK1: a rising star in inflammatory and neoplastic skin diseases. J Dermatol Sci 99(3):146\u2013151","journal-title":"J Dermatol Sci"},{"issue":"1","key":"8080_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","volume":"20","author":"J Yuan","year":"2019","unstructured":"Yuan J, Amin P, Ofengeim D (2019) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci 20(1):19\u201333","journal-title":"Nat Rev Neurosci"},{"issue":"22","key":"8080_CR7","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110\u20132121","journal-title":"N Engl J Med"},{"key":"8080_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.375","volume":"5","author":"H Fan","year":"2014","unstructured":"Fan H, Liu F, Dong G, Ren D, Xu Y, Dou J, Wang T, Sun L, Hou Y (2014) Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus. Cell Death Dis 5:e1416","journal-title":"Cell Death Dis"},{"issue":"8","key":"8080_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jid.2018.02.034","volume":"138","author":"F Lauffer","year":"2018","unstructured":"Lauffer F, Jargosch M, Krause L, Garzorz-Stark N, Franz R, Roenneberg S, Bohner A, Mueller NS, Theis FJ, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K (2018) Type i immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J Invest Dermatol 138(8):1785\u20131794","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8080_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13075-020-02332-7","volume":"22","author":"M Zhang","year":"2020","unstructured":"Zhang M, Jie H, Wu Y, Han X, Li X, He Y, Shi X, Luo Y, Sun Y, Yang J, Yang J, Quan S, Lao X, Tan L, Sun E (2020) Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity. Arthritis Res Ther 22(1):239","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"8080_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan X, Liu X, Liu N, Huang Y, Jin Z, Zhang S, Ming Z, Chen H (2020) Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis 11(2):134","journal-title":"Cell Death Dis"},{"key":"8080_CR12","doi-asserted-by":"crossref","unstructured":"Newton K (2020) Multitasking kinase RIPK1 regulates cell death and inflammation, Cold Spring Harb Perspect Biol 12(3)","DOI":"10.1101\/cshperspect.a036368"},{"key":"8080_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116123","author":"Y Bai","year":"2024","unstructured":"Bai Y, Qiao Y, Li M, Yang W, Chen H, Wu Y, Zhang H (2024) RIPK1 inhibitors: a key to unlocking the potential of necroptosis in drug development. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116123","journal-title":"Eur J Med Chem"},{"key":"8080_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105297","author":"L Cao","year":"2021","unstructured":"Cao L, Mu W (2021) Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2020.105297","journal-title":"Pharmacol Res"},{"key":"8080_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725\u20131734","journal-title":"Arthritis Rheum"},{"key":"8080_CR16","doi-asserted-by":"crossref","unstructured":"VDDA, Weening JJ, Schwartz MM, Seshan SV, Alpers CE, Appel GB (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited, Kidney International 65:521\u2013530.","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"issue":"1","key":"8080_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2215\/CJN.03280807","volume":"3","author":"YE Chen","year":"2008","unstructured":"Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ (2008) Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol 3(1):46\u201353","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"8080_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/eji.200324099","volume":"34","author":"JQ Yang","year":"2004","unstructured":"Yang JQ, Chun T, Liu H, Hong S, Bui H, Van Kaer L, Wang CR, Singh RR (2004) CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr\/lpr mice. Eur J Immunol 34(6):1723\u201332","journal-title":"Eur J Immunol"},{"key":"8080_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219247","author":"S Hayer","year":"2021","unstructured":"Hayer S, Vervoordeldonk MJ, Denis MC, Armaka M, Hoffmann M, Backlund J, Nandakumar KS, Niederreiter B, Geka C, Fischer A, Woodworth N, Bluml S, Kollias G, Holmdahl R, Apparailly F, Koenders MI (2021) \u2018SMASH\u2019 recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219247","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8080_CR20","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s10753-014-0081-1","volume":"38","author":"T Kilic","year":"2015","unstructured":"Kilic T, Parlakpinar H, Taslidere E, Yildiz S, Polat A, Vardi N, Colak C, Ermis H (2015) Protective and therapeutic effect of apocynin on bleomycin-induced lung fibrosis in rats. Inflammation 38(3):1166\u20131180","journal-title":"Inflammation"},{"issue":"4","key":"8080_CR21","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, D\u2019Agati VD, Ferrario F, Haas M, Jennette JC, Joh K, Nast CC, Noel LH, Rijnink EC, Roberts ISD, Seshan SV, Sethi S, Fogo AB (2018) Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93(4):789\u2013796","journal-title":"Kidney Int"},{"key":"8080_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.313","author":"EF Rosloniec","year":"2021","unstructured":"Rosloniec EF, Whittington K, Proslovsky A, Brand DD (2021) Collagen\u2010induced arthritis mouse model. Curr Protoc. https:\/\/doi.org\/10.1002\/cpz1.313","journal-title":"Curr Protoc"},{"issue":"2","key":"8080_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00011-022-01674-z","volume":"72","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yan C, Yu L, Zhang X, Shang J, Fan J, Zhang R, Ren J, Duan X (2022) The star target in SLE: IL-17. Inflamm Res 72(2):313\u2013328","journal-title":"Inflamm Res"},{"key":"8080_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914413","author":"P Richter","year":"2023","unstructured":"Richter P, Macovei LA, Mihai IR, Cardoneanu A, Burlui MA, Rezus E (2023) Cytokines in systemic lupus erythematosus\u2014focus on TNF-\u03b1 and IL-17. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914413","journal-title":"Int J Mol Sci"},{"issue":"5","key":"8080_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41581-022-00658-w","volume":"19","author":"B Kolbrink","year":"2023","unstructured":"Kolbrink B, von Samson-Himmelstjerna FA, Murphy JM, Krautwald S (2023) Role of necroptosis in kidney health and disease. Nat Rev Nephrol 19(5):300\u2013314","journal-title":"Nat Rev Nephrol"},{"key":"8080_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.05.014","volume":"103","author":"C Guo","year":"2019","unstructured":"Guo C, Fu R, Zhou M, Wang S, Huang Y, Hu H, Zhao J, Gaskin F, Yang N, Fu SM (2019) Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. J Autoimmun 103:102286","journal-title":"J Autoimmun"},{"key":"8080_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102890","author":"Y Xu","year":"2022","unstructured":"Xu Y, Li P, Li K, Li N, Liu H, Zhang X, Liu W, Liu Y (2022) Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2022.102890","journal-title":"J Autoimmun"},{"key":"8080_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1159743","author":"W Li","year":"2023","unstructured":"Li W, Yuan J (2023) Targeting RIPK1 kinase for modulating inflammation in human diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1159743","journal-title":"Front Immunol"},{"issue":"6","key":"8080_CR29","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1159\/000488179","volume":"45","author":"R Guo","year":"2018","unstructured":"Guo R, Tu Y, Xie S, Liu XS, Song Y, Wang S, Chen X, Lu L (2018) A role for receptor-interacting protein kinase-1 in neutrophil extracellular trap formation in patients with systemic lupus erythematosus: a preliminary study. Cell Physiol Biochem 45(6):2317\u20132328","journal-title":"Cell Physiol Biochem"},{"key":"8080_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001146","author":"L Peng","year":"2024","unstructured":"Peng L, Wang P, Xu X, Chen D, Xu F, Yang F, Yang S, Xia H, Liu Z-H, Qin W (2024) Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2024-001146","journal-title":"Lupus Sci Med"},{"key":"8080_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.624971","volume":"11","author":"T Koga","year":"2020","unstructured":"Koga T, Ichinose K, Kawakami A, Tsokos GC (2020) Current insights and future prospects for targeting IL-17 to treat patients with systemic lupus erythematosus. Front Immunol 11:624971","journal-title":"Front Immunol"},{"key":"8080_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-015-0070-7","volume":"16","author":"A Zickert","year":"2015","unstructured":"Zickert A, Amoudruz P, Sundstrom Y, Ronnelid J, Malmstrom V, Gunnarsson I (2015) IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. BMC Immunol 16:7","journal-title":"BMC Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08080-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:28:02Z","timestamp":1783398482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08080-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8080"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08080-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mice use was approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital of Zhejiang University. (No. 2021\u2013974).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}